1
|
Peres HA, Martinez EZ, Viana CM, Pereira LRL. Glycemic control and associated factors in patients with type 1 diabetes mellitus in primary care in Southeastern Brazil. BRAZ J PHARM SCI 2022. [DOI: 10.1590/s2175-97902022e20985] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023] Open
|
3
|
de Oliveira Vaz C, de Moraes Mazetto Fonseca B, Nascimento Silva Vasconcelos PE, Brito Bastos L, Cursino MA, Coelho França Quintanilha J, Tripiquia Vechiatto Mesquita GL, Rosa Dos Santos AP, Cardoso Jacintho B, Oliveira JD, Annichino-Bizzachi J, Andrade Orsi F. Self-perceived quality of life of primary antiphospholipid syndrome patients using vitamin K antagonist. Lupus 2021; 30:707-714. [PMID: 33509064 DOI: 10.1177/0961203321990079] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
PURPOSE Primary antiphospholipid syndrome (PAPS) is a chronic autoimmune disorder clinically characterized by thromboembolic events or obstetric complications. Prolonged anticoagulation therapy with vitamin K antagonists (VKA) is the treatment of choice for PAPS patients with thrombosis. However, the efficacy of VKA therapy depends on laboratory monitoring, dose adjustment, adequate lifestyle and adherence to treatment. Difficulties with VKA therapy can affect patients' self-perceived health related quality of life (HRQOL). This study aims to evaluate PAPS patients' HRQOL, therapy adherence and knowledge of treatment. METHODS A general Medical Outcome Study Short Form-36 (SF-36) and the Duke Anticoagulation Satisfaction Scale (DASS) were used to access APS-patients self-perceived HRQOL. Treatment adherence was measured by the Treatment Measure Adhesion (TMA) - oral anticoagulant version instrument, and knowledge of VKA treatment was measured using the MedTake test. RESULTS 66 PAPS patients using VKA were assessed. 63% of them were female; the mean age was 41.9 years old, approximately 60% had unprovoked venous thrombosis and one third of the patients had recurrent thrombotic events. The most impacted domain of DASS was "psychological impacts" and the factors associated to anticoagulation related poor HRQOL were: female sex, presence of arterial thrombosis and INR lability. Using the SF-36 instrument, PAPS-patients self-perceived HRQOL was poorer than that of the general Brazilian population and was associated with female sex and presence of cardiovascular risk factors. CONCLUSION Despite the high adherence to treatment and knowledge of VKA therapy, self-perceived HRQOL is poor in patients with PAPS and is mainly affected by VKA therapy. Searching for better treatment options is warranted.
Collapse
Affiliation(s)
- Camila de Oliveira Vaz
- Department of Pharmacology, School of Medical Sciences, University of Campinas, Campinas, SP, Brazil
| | | | | | | | - Maria Aparecida Cursino
- School of Medical Sciences, Department of Medical Sciences, University of Campinas, Campinas, SP, Brazil
| | | | | | - Ana Paula Rosa Dos Santos
- School of Medical Sciences, Department of Medical Sciences, University of Campinas, Campinas, SP, Brazil
| | - Bruna Cardoso Jacintho
- School of Medical Sciences, Department of Clinical Medicine, University of Campinas, Campinas, SP, Brazil
| | - José Diogo Oliveira
- School of Medical Sciences, Department of Clinical Medicine, University of Campinas, Campinas, SP, Brazil
| | - Joyce Annichino-Bizzachi
- School of Medical Sciences, Department of Clinical Medicine, University of Campinas, Campinas, SP, Brazil.,Hematology and Hemotherapy Center, University of Campinas, Campinas, SP, Brazil
| | - Fernanda Andrade Orsi
- Hematology and Hemotherapy Center, University of Campinas, Campinas, SP, Brazil.,School of Medical Sciences, Department of Clinical Pathology, University of Campinas, Campinas, SP, Brazil
| |
Collapse
|